KR200211912Y1 - A permeation apparatus for skin of medication - Google Patents

Abstract

The drug transdermal penetration device of the present invention has a close contact with a current frequency oscillator 30 in which a printed circuit board 37 is integrally installed under the body 31 and the current frequency oscillator 30 is fixed to the affected part B. A drug transdermal penetration device comprising a cloth 40 and a transdermal absorbent 60 attached to the current frequency oscillator 30 to infiltrate the drug into the affected part B by a current generated from the current frequency oscillator 30. The body 31, the printed circuit board 37, the contact cloth 40, and the transdermal absorbent 60 are configured to have a circular shape in plan view, and the printed circuit board 37 has a predetermined circumference thereof. A ring-shaped partitioning projection 37-1 which is integrally protruded into the ring-shaped partitioning projection 37-1, and a ring-shaped cathode terminal 38 which is provided around the edge of the partitioning projection 37-1 and is in direct contact with the annular portion B. And the inner side of the partition protrusion 37-1 so as not to contact the cathode terminal 38 at the center of the bottom surface thereof. Since it characterized in that the disk-shaped bipolar terminal 39 indirect contact with the affected part (B) via the transdermal absorbent (60), not only does not give the patient a sense of rejection, there is no fear of infection, It is convenient to use because it does not cause pain, and when applied to existing transdermal absorbents (foam type, patch type, cataplasm type, plata type, pape type, etc.), it increases the therapeutic effect by increasing the penetration effect of drugs. Of course, the treatment time can be shortened.

Description

Drug transdermal penetration device {A PERMEATION APPARATUS FOR SKIN OF MEDICATION}

The present invention relates to a drug transdermal penetration device that can be used by attaching a transdermal absorbent (for example, a formulation containing an injectable drug) to an electric current oscillator, and more particularly, a drug absorbed into a transdermal absorbent without using a syringe. The present invention relates to a drug transdermal penetration device capable of penetrating into the affected area.

In general, a widely used poultice agent is made of a fabric, coated with an adhesive agent on one side thereof, and a release paper made of vinyl, which can be separated upon use while protecting the drug, is attached to the wet cloth. In addition, the wet paper and the release paper are made of a flexible material so that they can be elastically attached to the skin.

Therefore, the use of the poultice agent is to treat the pain by the continuous penetration and pharmacological action of the drug while attaching the poultice agent to the affected area in the state of removing the release paper and maintain the adhered state for a certain time.

However, these poultices only treat the pain only by the pharmacological action of the drug applied to it, so the treatment effect is not only lowered, but the permeability of the drug gradually decreases, so after a certain period of time, the new poultice must be replaced with a new poultice. If the adhesion time of the poultice agent is longer than necessary, the pore of the skin in the state of elimination of the effect not only causes the itching of the affected area, but also had a disadvantage that the drug duration of the poultice agent could not be confirmed.

In addition, as a physiotherapy treatment of the hospital to improve the pain treatment effect of the affected area, in addition to the poultice method, a separate low-frequency generating device is in contact with the drug application surface in the state of applying the medicine directly to the affected area, but in this case, expensive As a result of the use of the device, the treatment cost is increased, and the patient is economically burdened, and there is an inconvenience in that the patient cannot perform self-therapy.

On the other hand, there is a spray gun-type drug sprayer having a liquid medicine is embedded as a poultice agent, in this case, by pressing the button of the sprayer to spray the medicine inside the container to the pain area for treatment, or use This was uncomfortable and had a disadvantage that the duration of the drug is lower than the poultice.

Therefore, the poultice is required to maximize the treatment effect in a short time and at the same time to simplify the treatment in consideration of the fact that the majority of patients with muscle and joint pain.

Therefore, conventionally, a low frequency generating poultice agent has been proposed under the registered patent number 245836 filed by the present applicant as a solution for this problem.

That is, the low frequency generating poultice agent 1 is provided with the wet paper 5a, 5b which contains a chemical | medical agent while separating into many pair as shown in FIGS. 1-3, and this wet paper 5a is carried out. An adhesive cloth 4 is attached to one surface of 5b, and the conductive plates 8a and 8b are interposed between the wet cloth papers 5a and 5b and the adhesive cloth 4.

In addition, the conductor plates 8a and 8b are separated from each other to correspond to the wet paper 5a and 5b while maintaining the state of being bonded to the upper surface of the wet paper 5a and 5b.

On the other hand, a low frequency generator 6 having an operation button 12 and positive and negative terminals 7a and 7b and including a battery (not shown) therein is provided for the positive and negative terminals 7a and 7b. The low frequency generator 6 is configured to be coupled between the conductor plates 8a and 8b, respectively, between the two wet papers 5a and 5b separated from each other.

In other words, the low frequency generator 6 is formed between the wet paper 5a and 5b so as to form a seat in the wet paper 5a and 5b in a predetermined shape, and the low frequency generator 6 Terminal grooves 9a and 9b are formed in the conductor plates 8a and 8b so that the positive and negative terminals 7a and 7b on both sides are coupled to each other, and the displacement and separation from the terminal grooves 9a and 9b are prevented. In order to prevent the positive and negative terminals (7a, 7b), the lower surface of the locking projections (11) which can be coupled to the wet paper (5a, 5b) is formed, respectively.

In addition, by attaching the release paper 10 made of vinyl on the chemical side of the wet paper (5a) (5b) to protect the chemical side and at the same time can be separated in use, the contact cloth (4) has a low frequency generator ( The button holes 2a and 2b are formed so that the operation button 12 and the up / down button 13 of 6) are exposed.

The adhesive cloth 4 has at least a circumferential length larger than the wet papers 5a and 5b, and release papers 3a and 3b to protect the adhesive layer while forming an adhesive layer bonded to the affected part on one surface thereof. Attached to form a poultice (1).

However, in the conventional low frequency generating foaming agent 1 comprised in this way, the conductor board 8a, 8b is interposed between the contact cloth 4 and the wet paper 5a, 5b, and this conductor board 8a is carried out. Since the low frequency generator 6 is integrally fixed to one side of the 8b), the low frequency generator 6, which is a relatively expensive part, is separated from the wet paper 5a and 5b and reused separately. In addition to the use of the conductor plates 8a and 8b, the manufacturing cost of the poultice agent 1 is high, and the low frequency generator 6 can be attached to an existing poultice agent commercially available for universal use. There was a downside.

Therefore, the present invention was devised to solve the above problems, and the object of the present invention is to use the current (direct current, frequency current) action of the current frequency oscillator and the affected part of the human body by using a drug containing a transdermal absorbent without using a syringe. Because it can penetrate inside, it does not give the patient a sense of rejection, it does not cause infection, it does not cause pain, it is convenient to use, and when it is applied to the existing transdermal absorbent, it increases the penetration effect of the drug. In addition, to provide a drug transdermal penetration device that can shorten the treatment time as well as increase.

Drug transdermal penetration device of the present invention made to achieve the above object, the current frequency oscillator with a printed circuit board is integrally installed in the lower portion of the body, the contact cloth for fixing the current frequency oscillator to the affected part, the attachment of the current frequency oscillator In the drug transdermal penetration device having a transdermal absorbent to penetrate the drug to the affected area by the current generated from the current frequency oscillator, the body, the printed circuit board, the contact cloth, the transdermal absorbent is configured to be circular in a planar view The printed circuit board includes a ring-shaped partitioning protrusion integrally formed at a predetermined circumferential surface of the printed circuit board, a ring-shaped cathode terminal provided around the edge of the partitioning projection and directly contacting the affected part, and at the center of the lower surface of the printed circuit board. It is installed inside the partition protrusion so as not to contact the cathode terminal and mediates the transdermal absorbent. It characterized in that it comprises a disk-shaped anode terminal indirect contact with the affected part.

In addition, the drug transdermal penetration device of the present invention is generated from the current frequency oscillator attached to the current frequency oscillator with a printed circuit board integrally installed in the lower part of the body, the contact cloth for fixing the current frequency oscillator to the affected part, and the current frequency oscillator In the drug transdermal penetration device having a transdermal absorbent which infiltrates the drug into the affected area by the current, the printed circuit board includes a partition protrusion integrally formed at the center of the lower surface thereof, and both sides of the partition protrusion relative to the lower surface of the printed circuit board. And a first terminal and a second transdermal absorbent attached to the bottom surface of the printed circuit board, respectively, which are respectively installed on the negative electrode terminal and the positive electrode terminal so as not to be in contact with each other.

1 is an exploded perspective view showing a conventional low-frequency generating poultice;

Figure 2 is a perspective view showing a conventional low frequency generating poultice,

3 is a sectional view showing the main parts of a conventional low-frequency generating poultice;

Figure 4 is an exploded perspective view showing a drug transdermal penetration device according to a first embodiment of the present invention,

Figure 5 is a side cross-sectional view showing a drug transdermal penetration device according to a first embodiment of the present invention,

Figure 6 is an exploded perspective view showing a drug transdermal penetration device according to a second embodiment of the present invention,

Figure 7 is a side cross-sectional view showing a drug transdermal penetration device according to a second embodiment of the present invention.

Explanation of symbols on the main parts of the drawings

30: current frequency oscillator 31: body

37,37a: printed circuit board 37-1,37a-1: partition projection

38,38a: negative terminal 39,39a: positive terminal

40: contact cloth 60: transdermal absorbent

60a, 60b: first and second transdermal absorbents

(First embodiment)

Hereinafter, a first embodiment of the present invention will be described in detail with reference to FIGS. 4 to 7.

Drug transdermal penetration device of the present invention, as shown in Figures 4 and 5, the current frequency oscillator 30 for generating a current (for example, low frequency or high frequency, etc.), and the upper edge of the current frequency oscillator 30 The adhesive cloth 40 attached to the affected part (B) while being used at the same time, the first release paper 50 attached to the lower surface of the adhesive cloth 40 when not in use, and the lower surface of the current frequency oscillator 30 It is composed of a transdermal absorbent 60 attached to the center and conducting current, and second and third reinforcements 70 and 71 attached to the upper and lower surfaces of the transdermal absorbent 60 when not in use.

That is, the current frequency oscillator 30 is a body 31 formed in a circular shape in a plan view, and has an on / off button 32 and an up / down button at regular intervals on the upper surface of the body 31. 33) and a signal mode unit 34, respectively, and a battery 35, a control element 36, and the like are built into the body 31.

The printed circuit board 37 having a larger diameter than the body 31 is integrally attached to the bottom surface of the body 31 while forming a circular shape in a plane and concentric with the body 31. Around the edge of the circuit board 37, a negative electrode terminal 38 having a ring-shaped cross section and having a sectional shape in a planar view is provided so as to be in direct contact with the annular portion B. The printed circuit board 37 In the center of the lower surface thereof, a positive electrode terminal 39 is formed in a disc shape when viewed from the lower surface so as to contact the transdermal absorbent 60.

The battery 35 may be configured not to be separated from the body 31 or may be configured to be replaceable from the body 31.

A ring-shaped partitioning protrusion 37-1 is integrally protruded so that the negative electrode terminal 38 and the positive electrode terminal 39 do not come into contact with each other at a predetermined circumference of the lower surface of the printed circuit board 37.

The negative electrode terminal 38 is made of a conductive material of a soft material that does not give a sense of rejection to the human body.

The negative electrode terminal 38 and the positive electrode terminal 39 may be configured to change the polarity of each other according to the design change.

On the other hand, the contact cloth (40) and the first foil 50 is formed in a ring shape having the same diameter as each other in plan view, the inner circumference with respect to the lower surface of the contact cloth 40 is the current frequency oscillator (30) ) Is attached to the upper surface of the printed circuit board 37, the periphery of the adhesive cloth 40 is attached to the annular portion (B).

The transdermal absorbent 60 and the first and second delaminations 70 and 71 are circular in shape with the same diameter in plan view, and the transdermal absorbent 60 has a larger outer circumferential surface than the anode terminal 39. At the same time, the outer peripheral surface is made smaller than the inner peripheral surface of the negative electrode terminal 38 is attached to the lower surface of the printed circuit board 37.

Next, the operation and effects by the present invention configured as described above will be described.

In order to assemble and use the current frequency oscillator 30 and the transdermal absorbent 60, which are sold separately from each other as shown in FIG. 4, first and second and third respectively attached to the upper and lower surfaces of the transdermal absorbent 60, respectively. After peeling off the release papers 70 and 71, the lower surface of the transdermal absorbent 60 is attached to the lower surface of the printed circuit board 37 by using the adhesive applied on the upper surface of the transdermal absorbent 60. Attach to affected part (B).

Then, after removing the first peeling paper 50 attached to the lower surface of the adhesive cloth 40, the inner circumference of the lower surface of the adhesive cloth 40 is printed using the adhesiveness applied to the lower surface of the adhesive cloth 40. The outer periphery of the bottom surface of the contact cloth 40 is attached to the annular portion B while being attached to the upper surface of the circuit board 37.

At this time, the body 31 of the current frequency oscillator 30 protrudes to the outside through a hole drilled in the center of the contact cloth 40, the printed circuit board 37 installed on the lower surface of the body 31 is the contact cloth. As shown in FIG. 5, the lower surface of the 40 is in close contact with the annular portion B so that the lower surface of the negative electrode terminal 38 attached to the edge side of the printed circuit board 37 is in direct contact with the annular portion B so that the current Is placed in a state capable of conducting, and the transdermal absorbent 60 attached to the center of the lower surface of the printed circuit board 37 is brought into direct contact with the affected part B while the printed circuit board 37 and the transdermal absorbent 60 are in contact with each other. The current generated from the anode terminal 39 provided in the maintains the state that can flow to the affected part (B).

In this state, by pressing the ON / OFF button 32 installed in the body 31 of the current frequency oscillator 30 to ON, and then pressing the up / down button 33 to select the vibration mode, the body The frequency of the vibrations is caused by the program action of the control elements 36 embedded in the 31, and the vibration mode is configured to be converted to at least five or more steps. Each time you press), you can select the desired vibration mode.

Therefore, according to the operation of the current frequency oscillator 30 Wow When a current is generated, the current penetrates into the subcutaneous tissue of the skin and absorbs the drug absorbed by the transdermal absorbent (60). Wow It acts as a quick and uniform loading by the current action of the anode separated by.

And, the operation is a certain time (10 minutes) is a frequency oscillation action, and if it is about 60 minutes is a time to penetrate the drug components by conducting only a direct current continuously without the frequency oscillation and again 10 minutes is the action of frequency oscillation It can be done automatically and repeatedly.

That is, the negative electrode terminal 38 of the edge of the printed circuit board 37 is in contact with the annular portion B, and the positive electrode terminal 39 of the lower surface of the printed circuit board 37 is in contact with the transdermal absorbent 60 and is applied to the DC. Since the current is configured to flow, when the on / off button 32 is pressed to operate the current frequency oscillator 30, an example in which the anode terminal 39 is transferred to the affected part B through the transdermal absorbent 60 is shown. For example, the cathode low frequency component and the cathode low frequency component transferred from the cathode terminal 38 to the affected part B are connected to each other. Wow The low frequency action by the direct current of is started to be activated.

As such, the drug permeation from the transdermal absorbent 60 itself and the penetration of the drug component by the electric current at the same time not only actively the pharmacological action, but also quickly alleviate the pain in the affected area (B) by the frequency vibration stimulation of the electric current. By releasing the help to blood circulation can be expected faster faster.

This phenomenon is a method of transferring the ions of the drug into the body through the affected part (B) with the use of a constant current, the principle of which ions move towards the charged electrode under the nutrition of ELECTRMOTIVE FORCE. It is based on the phenomenon.

Accordingly, when the drug or the transdermal absorbent 60 containing the drug is brought into contact with the positive electrode terminal 39, and the negative electrode terminal 38 is brought into contact with the affected part B of the human body, the drug contained in the transdermal absorbent 60 is formed. The action of the ions to move toward the cathode terminal 38 through the affected part (B) is to be able to penetrate the drug ions through the capillaries of the affected part (B).

Thus, the drug can be penetrated into the affected part (B) of the human body without using a syringe, thereby not only giving a feeling of rejection to the patient but also causing no fear of infection, and thus, it is convenient to use.

In addition, when applied to existing transdermal absorbents (foam type, patch type, cataplasm type, plata type, pape type, etc.), the penetration effect of the drug is increased, thereby increasing the therapeutic effect and shortening the treatment time. .

On the other hand, when the battery 35 built in the current frequency oscillator 30 has a capacity that can be used by replacing a plurality of transdermal absorbents 60 every time in the case of an integrated type, when the battery 35 is exhausted. Until it can be used to replace the transdermal absorbent 60. That is, when the drug component of the transdermal absorbent 60 disappears, the adhesive cloth 40, the transdermal absorbent 60, and the current frequency oscillator 30 are separated from the affected part B, and then the drug component is removed. ) To separate and discard.

Then, a new transdermal absorbent 60 commercially available for the current frequency oscillator 30 can be replaced and used in the same manner as described above, and the battery 35 contained in the current frequency oscillator 30 can be replaced. In this case, it is possible to reuse the current frequency oscillator 30.

Therefore, the transdermal absorbent 60 and the current frequency oscillator 30 can be separated and assembled so that the transdermal absorbent 60 can be used as a consumable product and the current frequency oscillator 30 can be reused. The percutaneous absorbent 60 can be used by applying all, reuse the multiple transdermal absorbers 60 with the current frequency oscillator 30, and apply the current (direct current, frequency current) to the transdermal absorbent 60 to the affected part (skin ) Can help a lot.

Second Embodiment

In the above description, the positive terminal 39 of the printed circuit board 37 is indirectly contacted with the affected part B of the human body via the transdermal absorbent 60, and the negative terminal 38 of the printed circuit board 37 is the human body. Drug transdermal penetration device that is in direct contact with the affected part (B) of the present invention has been described as an example, but the present invention is not limited to this, for example, as shown in Figures 6 and 7 as the second embodiment The negative electrode terminal 38a and the positive electrode terminal 39a are respectively provided at predetermined intervals on both sides of the lower surface of the printed circuit board 37a of the main oscillator 30a, and the negative terminal 38a and the positive electrode terminal 39a are respectively attached to each other. The first and second transdermal absorbents 60a and 60b are attached to the lower surface of the printed circuit board 37.

At this time, the partition protrusion 37a-1 is integrally formed at the center of the lower surface of the printed circuit board 37 so that the negative electrode terminal 38a and the positive electrode terminal 39a do not contact each other.

The first and second transdermal absorbents 60a and 60b are formed in a disc shape when they face each other in a symmetrical manner, and the upper and lower surfaces of the first and second transdermal absorbents 60a and 70b and the third night are not used. Ridges 71a and 71b are attached, respectively.

As described above, the drug transdermal penetration device of the present invention has a structure in which the transdermal absorbent can be detachably used in the current frequency oscillator, so that it is not necessary to prepare a transdermal absorbent in particular, and is widely used in the market. It can be used to accommodate all of them, and it is economical because several transdermal absorbents can be used as one current frequency oscillator.

In addition, since the drug contained in the transdermal absorbent can be penetrated deeply into the affected area by the action of the current frequency oscillator, the patient caused by using the syringe can eliminate the rejection, and it is convenient to use because there is no fear of infection and pain. Rather, it will increase the therapeutic effect and at the same time shorten the treatment time.

Claims (5)

The current frequency oscillator 30 in which the printed circuit board 37 is integrally installed under the body 31, the contact cloth 40 for fixing the current frequency oscillator 30 to the affected part B, and the current frequency. In the drug transdermal penetration device having a transdermal absorbent 60 attached to the oscillator 30 to infiltrate the drug into the affected part B by the current generated from the current frequency oscillator 30, The body 31, the printed circuit board 37, the contact cloth 40, the transdermal absorbent 60 is configured to have a circular shape in plan view, The printed circuit board 37, A ring-shaped partition protrusion 37-1 protruding integrally at a predetermined circumference thereof; A ring-shaped negative electrode terminal 38 installed around the edge of the partition protrusion 37-1 and directly contacting the annular portion B; The plate-shaped anode terminal is installed inside the partition protrusion 37-1 so as not to contact the cathode terminal 38 at the bottom thereof and indirectly contacts the affected part B via the transdermal absorbent 60 ( 39) drug transdermal penetration device, characterized in that the configuration. The method of claim 1, The adhesive cloth 40, while protruding the body 31 to the outside and at the same time surrounds the upper surface of the printed circuit board 37, the drug transdermal penetration, characterized in that configured in the ring shape to be attached to the affected part (B) Device. The method of claim 1, The transdermal absorbent (60) is a drug transdermal penetration device, characterized in that formed in the shape of a disk that forms a larger outer peripheral surface than the inner peripheral surface of the cathode terminal 38 and at the same time larger than the positive electrode terminal (39). The current frequency oscillator 30 in which the printed circuit board 37 is integrally installed under the body 31, the contact cloth 40 for fixing the current frequency oscillator 30 to the affected part B, and the current frequency. In the drug transdermal penetration device having a transdermal absorbent 60 attached to the oscillator 30 to infiltrate the drug into the affected part B by the current generated from the current frequency oscillator 30, The printed circuit board 37a, The partition projection 37a-1 which is integrally formed at the center of the lower surface thereof, A negative electrode terminal 38a and a positive electrode terminal 39a which are provided on both sides of the partition protrusion 37a-1 with respect to the bottom surface thereof and are not in contact with each other; Drug transdermal penetration characterized in that the first and second transdermal absorbents (60a, 60b) attached to the lower surface of the printed circuit board 37, respectively opposite to the negative electrode terminal 38a and the positive electrode terminal 39a, respectively. Device. The method of claim 4, wherein The first and second transdermal absorbents (60a) (60b), drug transdermal penetration device, characterized in that each configured in a semi-circular plate shape opposite to each other in plan view.